These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 628105)

  • 1. [Anti-thromboembolic therapy and effects of dipyridamole on platelet function in patients with heart valve prostheses (authors transl)].
    Tokumo M; Doko S; Ono Y; Takabatake T; Noguchi A; Omoto T; Teramoto S
    Kyobu Geka; 1978; 31(1):19-22. PubMed ID: 628105
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of antiplatelet drug therapy and replaced heart valves based on platelet functions].
    Nasu M; Shikano K; Miyamura K; Shinpo H; Morimoto T; Ohi T; Shomura S; Yamazaki N; Yada I; Kusagawa M
    Kyobu Geka; 1983 Sep; 36(9):701-5. PubMed ID: 6632428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
    Ben Ismail M; Ghariani M; Jais JM
    Nouv Presse Med; 1975 Mar; 4(10):746 (2). PubMed ID: 1129046
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
    Starkman C; Estampes B; Vernant P; Acar J
    Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
    Dale J; Myhre E; Rootwelt K
    Am Heart J; 1975 May; 89(5):613-8. PubMed ID: 1119369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].
    Saitoh H; Matsumoto H; Takayama T; Ide H; Miyawaki F; Furuse A
    Kokyu To Junkan; 1989 Jan; 37(1):87-92. PubMed ID: 2734499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 11. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thromboembolism prevention after heart valve prosthesis in an experimental model].
    Dragojevic D; Hetzer R; Corterier H
    Thoraxchir Vask Chir; 1972 Dec; 20(6):419-23. PubMed ID: 4539570
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late results of mitral and aortic valve replacement.
    Bonchek LI; Starr A
    Isr J Med Sci; 1975; 11(2-3):152-60. PubMed ID: 1112701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
    Bouvier CA
    Ther Umsch; 1974 Feb; 31(2):84-8. PubMed ID: 4612856
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Miller MM; Hipp R; Matsumura ME
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1167-9. PubMed ID: 18669529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
    Wyss M; Diez C; Balavoine JF; Martin D; Bouvier CA
    Eur J Cardiol; 1978 Oct; 8(3):337-47. PubMed ID: 710491
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW; Buckley FO; Green RM; Schwartz SI; DeWeese JA
    Surgery; 1978 Jul; 84(1):37-44. PubMed ID: 149385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.